Pantoprazol Orion (Pantoprazole Sodium Sesquihydrate)

Pantoprazol Orion is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Erosive duodenal ulcer: accelerates ulcer healing and reduces recurrence risk.
• Erosive gastric ulcer: supports ulcer resolution and prevents relapse.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• NSA‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term non‑steroidal anti‑inflammatory therapy.

• Pantoprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, allowing the gastrointestinal mucosa to heal and maintain a higher gastric pH.

Pantoprazol Orion may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: watery stools without blood.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: cramp‑like discomfort.
• Flatulence: increased intestinal gas.
• Constipation: infrequent, hard stools.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhoea, fever, abdominal pain.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Vitamin B12 deficiency: fatigue, neuropathy with long‑term use.
• Fracture risk: reduced bone mineral density with prolonged therapy.

Pantoprazol Orion should be used with consideration of several safety aspects.

• Renal impairment: dose adjustment may be required in severe kidney disease.
• Hepatic impairment: monitor liver function in patients with moderate to severe liver disease.
• Long‑term use: assess need periodically to avoid unnecessary prolonged exposure.
• Drug interactions: review concomitant medications for potential pharmacokinetic effects.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole can affect the absorption and metabolism of several co‑administered drugs.

Major Interactions (Avoid)

• Ketoconazole or itraconazole: reduced antifungal absorption; avoid concurrent use.
• Atazanavir: markedly decreased antiviral exposure; avoid.
• Clopidogrel: diminished antiplatelet effect; consider alternative therapy.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation parameters.
• Methotrexate: reduced renal clearance; check serum levels.
• Digoxin: slight increase in serum concentration; observe for toxicity signs.
• Iron supplements: decreased iron absorption; separate dosing by at least 2 hours.